Cardia’s Ultrasept Atrial Septal Defect Closure Device
The Ultrasept ASD Occluder has been developed for the transvenous closure of atrial septal defects. The dual articulating sails along with the patented self-centering mechanism allows for easy deployment of the device as well as a super-low profile within the atria.
The patented self-centering mechanism is incorporated into the device for optimal positioning and repositioning of the device within the defect. An integral locking delivery and retrieval mechanismensures safe and stable deployments.
Ultrasept ASD devices are right side retrievable, which allows a device to be positioned as many times necessary to ensure accuracy during deployment.